CDK8-mediated STAT1-S727 phosphorylation restrains NK cell cytotoxicity and tumor surveillance

Eva Maria Putz1, Dagmar Gotthardt, Gregor Hoermann

  • 1Institute of Pharmacology and Toxicology, Department for Biomedical Sciences, University of Veterinary Medicine Vienna, 1210 Vienna, Austria.

Cell Reports
|August 13, 2013
PubMed

Insights

Mutating a specific site on STAT1 enhances natural killer (NK) cell anti-tumor activity. This finding suggests targeting CDK8 could boost NK cell immunity against cancers like melanoma and leukemia.

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • Natural killer (NK) cells are crucial for innate immunity against tumors and viral infections.
  • The transcription factor STAT1 plays a key role in NK cell function.
  • STAT1 phosphorylation at serine 727 (S727) influences NK cell activity.

Purpose of the Study:

  • To investigate the impact of mutating the STAT1 S727 phosphorylation site on NK cell function and anti-tumor immunity.
  • To explore the role of cyclin-dependent kinase 8 (CDK8) in STAT1 phosphorylation.
  • To evaluate the therapeutic potential of inhibiting CDK8 for cancer immunotherapy.

Main Methods:

  • Site-directed mutagenesis of STAT1 at S727 (Stat1-S727A).
  • Assessment of NK cell cytotoxicity against various tumor cell lines.
  • Measurement of perforin and granzyme B expression in NK cells.
  • In vivo studies using Stat1-S727A mice in tumor models (melanoma, leukemia, breast cancer).
  • Pharmacological inhibition of CDK8.

Main Results:

  • Mutation of Stat1-S727A significantly enhanced NK cell cytotoxicity.
  • Stat1-S727A mutation led to increased expression of cytotoxic effector molecules perforin and granzyme B.
  • Stat1-S727A mice exhibited delayed tumor progression in multiple cancer models.
  • Constitutive S727 phosphorylation was dependent on CDK8 activity.

Conclusions:

  • STAT1 phosphorylation at S727 negatively regulates NK cell cytotoxic function.
  • Targeting CDK8 to inhibit STAT1-S727 phosphorylation can enhance NK cell-mediated anti-tumor surveillance.
  • Inhibition of CDK8 represents a potential therapeutic strategy for augmenting anti-cancer immunity.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...